Activity Overview
This course is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by Board of Pharmacy Specialties (BPS). The course consists of 9 learning modules (see table below) and provides up to 20.5 contact hours of continuing pharmacy education and/or recertification credit.
Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this course, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ACCP and ASHP professional development program for BCPPS recertification approved by the BPS.
Accreditation

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
The target audience for PedSAP 2026 is board-certified and advanced level pediatric care clinical pharmacists.
Recertification Credit*
Board certified pharmacists are eligible to receive up to 20.5 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

ACCP and ASHP are approved by BPS as a provider for the recertification of BCPPS.
|
Learning Activity |
ACPE Number |
Contact Hours |
Assessment Pass Point |
Chapter: Skin and Soft Tissue Infections
|
0217-9999-26-173-H01-P |
2.0 |
73% |
Chapter: Novel Antiseizure Medications
|
0217-9999-26-174-H01-P |
2.5 |
60% |
Chapter: Pediatric Hypertension
|
0217-9999-26-175-H01-P |
3.0 |
66% |
Chapter: Anemia of the Pediatric Patient
|
0217-9999-26-176-H01-P |
3.0 |
66% |
Chapter: Growth Hormone Therapy
|
0217-9999-26-177-H01-P |
1.5 |
66% |
Chapter: Inflammatory Bowel Disease
|
0217-9999-26-178-H01-P |
3.0 |
66% |
Case Series: Pediatric Palliative and Hospice Care
|
0217-9999-26-179-H08-P |
2.0 |
66% |
Case Series: Cystic Fibrosis Update
|
0217-9999-26-180-H01-P |
1.5 |
66% |
| Case Series: Pregnancy Emergencies |
0217-9999-26-181-H01-P |
2.0 |
66% |
| |
|
20.5 BPS & ACPE |
|
System Technical Requirements
Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
Development
ACCP and ASHP collaborate on pediatric care pharmacy activities.